Based on 3 analysts giving stock ratings to Dare Bioscience Inc in the past month.
In the current month, DARE has received 3 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. DARE average Analyst price target in the last month is 8.333.
Based on analysts' estimates, DARE EPS is projected to reach -0.260 in FY2026Q3, following reported EPS of -0.200 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
The market expectation was USD -0.20, while Dare Bioscience IncDARE's earnings per share (EPS) for the previous quarter was USD -0.21. EPS for the next quarter is expected at USD -0.26.